Medihub Prostate
Overview
MEDIHUB Prostate is an AI-powered software solution developed by JLK for the diagnosis of prostate cancer. It functions by analyzing multi-parametric prostate Magnetic Resonance (MR) images and assessing prostate-specific antigen (PSA) levels to assist trained radiologists and urologists in their clinical interpretation of prostate MR studies. The solution semi-automatically outlines the prostate region, performs multi-parametric MRI image registration, and provides a user-interaction module for editing and approving the computed prostate outline. It supports the review and analysis of prostate MR data through computed modules and presents the analysis results in various formats, including images overlaid onto source MR images and structured reports. MEDIHUB Prostate was developed through clinical trials in collaboration with Seoul Asan Hospital and the University of Missouri.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-based analysis of multiparametric prostate MR images
- Assessment of prostate-specific antigen (PSA) levels
- Semi-automatic prostate region outlining
- Multi-parametric MRI image registration
- User-interaction for editing and approving prostate outlines
- Provides comprehensive diagnostic data including PIRADS assessment
- Web-based user interface
- PACS interworking for convenient patient data management
- Heat-map output for AI prediction probability
- Customized patient report generation
Use Cases
- Assisting in prostate cancer diagnosis
- Analysis of prostate MR images
- Clinical interpretation of prostate MR studies
- Monitoring prostate cancer
- Reducing reading time for radiologists
- Supporting informed decisions regarding patient management
What Physicians Need to Know
Medihub Prostate offers a valuable AI-powered diagnostic aid for prostate cancer, leveraging multiparametric MRI and PIRADS scoring. Physicians should note its FDA clearance and collaborative development with academic centers, indicating a robust foundation. While the AI provides semi-automatic outlining and data analysis, active user interaction for editing and confirming results remains crucial, as it is not a fully autonomous diagnostic tool. Consider its compatibility with existing Siemens 3T MRI systems and its focus on patients aged 55 and above. The integration of PSA density alongside imaging data can enhance diagnostic precision.
Medihub Prostate is designed for web-browser access and supports the DICOM standard, facilitating integration into existing radiology workflows and PACS systems. JLK Group's broader AI platforms emphasize seamless connection with in-hospital systems, suggesting a user-friendly integration pathway for Medihub Prostate. Healthcare providers should confirm specific API availability and compatibility with their Electronic Health Record (EHR) and Picture Archiving and Communication System (PACS) for optimal data flow and workflow efficiency.
Details
| Category | Oncology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing — Contact for pricing |
| Deployment | Web-based |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
1 AI-estimated MEDIHUB Prostate received 510(k) clearance from the U.S. FDA on June 21, 2024, under premarket notification K233196. It is an image processing software package intended to assist trained radiologists and urologists in the clinical interpretation of prostate MR studies. |
| Integrations | |
| EHR | Not specified |
| Specialties | Oncology, Radiology, Urology |
What the Web Says
Medihub Prostate is an AI-powered image processing software developed by JLK in collaboration with Asan Medical Center and the University of Missouri. It assists in the diagnosis and monitoring of prostate cancer by analyzing prostate MR images and integrating AI to provide comprehensive diagnostic data, including PI-RADS assessment and PSA density. The software received 510(k) clearance from the U.S. FDA in June 2024, which has led to a significant surge in JLK's shares.
Overall: PositiveStrengths
- FDA 510(k) clearance, indicating safety and effectiveness
- Utilizes deep learning for semi-automatic prostate outlining on MR images
- Supports study review and analysis of prostate MR data with computed modules
- Provides analysis results in various formats, including images overlaid on source MR images and structured reports
- Offers additional functionalities like registered multiparametric-MRI viewing and combining MR sequences
- Aids in prostate cancer diagnosis by analyzing MR images and assessing PSA levels
Limitations
- Validated for use only with Siemens 3T Vida and Skyra MRI machines
- Designed for use with Siemens 3T T2 MRI series, supporting specific slice thicknesses (3.5 mm to 5 mm)
- Tested on patients aged 55 years and above
- Patient management decisions should not be made solely based on the software's analysis
- No readily available reviews from independent tech reviewers, Reddit, G2, or Capterra at this time.
- Requires user editing and confirmation of the final semi-automatically outlined prostate region
Based on reviews from: FDA.report, KBR, KED Global, JLK Group Website
Last updated: 2026-07-18
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Medihub Prostate
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for Medihub Prostate.
The Reality About Frequency: How Habitual Intimacy Supports Prostate Health
